Recruiting Leukemia Studies in Rio De Janeiro
About Leukemia Clinical Trials in Rio De Janeiro
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 1 leukemia clinical trials recruiting participants in Rio De Janeiro, RIO%20DE%20JANEIRO. These studies are seeking a combined 347 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Rio De Janeiro — FAQ
Are there leukemia clinical trials in Rio De Janeiro?
Yes, there are 1 leukemia clinical trials currently recruiting in Rio De Janeiro, RIO%20DE%20JANEIRO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rio De Janeiro?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rio De Janeiro research site will contact you about next steps.
Are clinical trials in Rio De Janeiro free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rio De Janeiro studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 1 active trials in Rio De Janeiro are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov